Medical Expert Weighs in on Slimming Agents

College of Osteopathic Medicine Assistant Professor Eleanor Yusupov, D.O., has been featured in a WeightWatchers blog post noting the key differences between weight-loss medications Zepbound and Mounjaro. While both are FDA-approved using active ingredient tirzepatide, the nuances of each make them better suited for different patients.

“Mounjaro is approved for individuals with type 2 diabetes, while Zepbound is approved for weight loss and obstructive sleep apnea in people with obesity,” explains Yusupov, an obesity medicine physician. “Zepbound is different…because it [mimics] two gut hormones—GLP-1 and GIP.”